Insulin resistance in the sisters of women with polycystic ovary syndrome: Association with hyperandrogenemia rather than menstrual irregularity

Journal of Clinical Endocrinology and Metabolism

Volumn 87, Issue 5, 2002, Pages 2128-2133

  Legro, Richard S ^a,b,c,d,e   Bentley Lewis, Rhonda ^a,b,c,d   Driscoll, Deborah ^a,b,c,d   Wang, Steve C ^a,b,c,d   Dunaif, Andrea ^a,b,c,d  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b PENN STATE COLLEGE OF MEDICINE   (United States)

^c UNIVERSITY OF PENNSYLVANIA   (United States)

^d HARVARD UNIVERSITY   (United States)

^e NORTHWESTERN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FOLLITROPIN; GLUCOSE; INSULIN; LUTEINIZING HORMONE; PRASTERONE SULFATE; SEX HORMONE BINDING GLOBULIN; TESTOSTERONE;

ADULT; ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; HYPERANDROGENISM; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; INSULIN SENSITIVITY; MAJOR CLINICAL STUDY; MENSTRUATION DISORDER; OBESITY; OVARY POLYCYSTIC DISEASE; PRIORITY JOURNAL; SIBLING; TESTOSTERONE BLOOD LEVEL;

FALLOPIA;

EID: 0036095697     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jcem.87.5.8513     Document Type: Article

References (49)

1. Insulin resistance and the polycystic ovary syndrome: Mechanism and implications for pathogenesis
2. Suppression of serum insulin by diazoxide reduces serum testosterone levels in obese women with polycystic ovary syndrome
3. Improvement in endocrine and ovarian function during dietary treatment of obese women with polycystic ovary syndrome
4. The insulin-sensitizing agent troglitazone improves metabolic and reproductive abnormalities in the polycystic ovary syndrome
5. Decreases in ovarian cytochrome P450C17-α activity and serum free testosterone after reduction of insulin secretion in polycystic ovary syndrome
6. Ovulatory and metabolic effects of d-chiro-inositol in the polycystic ovary syndrome
7. Heriditary factors in the Stein-Leventhal syndrome
8. The inheritance of polycystic ovarian disease and a possible relationship to premature balding
9. Familial clustering in the polycystic ovarian syndrome
10. Evidence for a single gene effect causing polycystic ovaries and male pattern baldness
11. Polycystic ovaries are inherited as an autosomal dominant trait: Analysis of 29 polycystic ovary syndrome and 10 control families
12. Evidence for a genetic basis for hyperandrogenemia in polycystic ovary syndrome
13. Characterization of groups of hyperandrogenic women with acanthosis nigricans, impaired glucose tolerance, and/or hyperinsulinemia
14. The relationship of insulin insensitivity to menstrual pattern in women with hyperandrogenism and polycystic ovaries
15. Endogenous inhibitors of 11β-hydroxysteroid dehydrogenase type 1 do not explain abnormal cortisol metabolism in polycystic ovary syndrome
16. Prevalence of polycystic ovary syndrome (pcos) in first-degree relatives of patients with pcos
17. A twin study of polycystic ovary syndrome
18. Excessive insulin receptor serine phosphorylation in cultured fibroblasts and in skeletal muscle. A potential mechanism for insulin resistance in the polycystic ovary syndrome
19. Augmented androgen production is a stable steroidogenic phenotype of propagated theca cells from polycystic ovaries
20. 1rs-2 pathways integrate female reproduction and energy homeostasis
21. Role of brain insulin receptor in control of body weight and reproduction
22. Ethnicity and polycystic ovary syndrome are associated with independent and additive decreases in insulin action in Caribbean-Hispanic women
23. Racial differences in the relation between blood pressure and insulin resistance
24. Insulin resistance, secretion, and metabolism in users of oral contraceptives
25. Normalization of insulin resistance in non-obese essential hypertension by cilazapril treatment
26. Troglitazone improves ovulation and hirsutism in the polycystic ovary syndrome: A multicenter, double blind, placebo-controlled trial
27. Hirsutism: Implications, etiology, and management
28. Evaluation of WHO and NDDG criteria for impaired glucose tolerance. Results from two national samples
29. Inheritance of low erythrocyte catechol-o-methyltransferase activity in man
30. A fasting glucose to insulin ratio is a useful measure of insulin sensitivity in women with polycystic ovary syndrome
31. Hyperinsulinemia is common in family members of women with polycystic ovary syndrome
32. Familial clustering of arterial blood pressure, hdl cholesterol, and pro-insulin but not of insulin resistance and microalbuminuria in siblings of patients with type 2 diabetes
33. Plasma insulin, C-peptide, and proinsulin concentrations in obese and nonobese individuals with varying degrees of glucose tolerance
34. Insulin resistance and insulin secretory dysfunction as precursors of non-insulin-dependent diabetes mellitus. Prospective studies of Pima Indians
35. Heritability of insulin secretion and insulin action in women with polycystic ovary syndrome and their first degree relatives
36. β-cell dysfunction, rather than insulin insensitivity, is the primary defect in familial type 2 diabetes
37. Insulin resistance and obesity. The role of fat distribution pattern
38. Fasting glucose to insulin ratio, or product of glucose and insulin?
39. A direct effect of hyperinsulinemia on serum sex hormone-binding globulin levels in obese women with the polycystic ovary syndrome
40. Effects of metformin on spontaneous and clomiphene-induced ovulation in the polycystic ovary syndrome
41. Role of hyperinsulinemia in the pathogenesis of the polycystic ovary syndrome, and its clinical implications
42. Characterization of the inappropriate gonadotropin secretion in polycystic ovary syndrome
43. Effect of the genetic background on the reproduction of leptin-deficient obese mice
44. Leptin concentrations in the polycystic ovary syndrome
45. Prevalence and predictors of risk for type 2 diabetes mellitus and impaired glucose tolerance in polycystic ovary syndrome: A prospective, controlled study in 254 affected women
46. Evidence for association between polycystic ovary syndrome and premature carotid atherosclerosis in middle-aged women